RNase Inhibitor and 2 more items

Life Technologies Corporation, headquartered in Pittsburgh, Pennsylvania, was awarded a purchase order (PO) by the University of Nebraska Medical Center (UNMC), a state agency under the Board of Regents of the University of Nebraska, for laboratory reagents and molecular biology supplies. The contract, issued May 26, 2026, with completion scheduled for May 28, 2026, carries a total contract value of $2,287.66. Performance will take place at UNMC's facility in Omaha, Nebraska.

The contract encompasses three molecular biology products: eight units of RNase Inhibitor at $109.81 per unit ($878.48 total); one unit of High-Capacity complementary deoxyribonucleic acid (cDNA) Reverse Transcription at $1,206.40; and one unit of Assay ID Hs00174128_m1 TaqMan Gene Expression product at $202.78. These reagents are intended to support molecular analysis and gene expression research activities at the institution. Delivery is on a Free On Board (FOB) destination basis with freight prepaid, and payment terms are Net 30 with Nebraska State Treasury warrants accepted as payment method.